The latest Reclast study emphasizes the importance of treating osteoporosis patients after a hip fracture

The latest Reclast study emphasizes the importance of treating osteoporosis patients after a hip fracture.

Elderly patients who break a hip have a high risk of disability, future fractures, and even death.

Now there's evidence that Reclast (zoledronic acid) reduces the risk of a second fracture and improves survival in these patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote